{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:40:21Z","timestamp":1781192421368,"version":"3.54.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ijrobp.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T15:50:06Z","timestamp":1521388206000},"page":"860-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The Children's Oncology Group Radiation Oncology Discipline: 15\u00a0Years of Contributions to the Treatment of Childhood Cancer"],"prefix":"10.1016","volume":"101","author":[{"given":"John C.","family":"Breneman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Constine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold C.","family":"Paulino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Followill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Laack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natia","family":"Esiashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Haas-Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran","family":"Laurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Olch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Ulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torunn I.","family":"Yock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Terezakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Krasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Panoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Chuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ho","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton B.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Wolden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Buchsbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kalapurakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.03.002_bib1","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib2","series-title":"Pediatric radiation oncology","author":"Constine","year":"2016"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib3","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib4","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1200\/JCO.2000.18.16.3004","article-title":"Low-stage medulloblastoma: Final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation","volume":"18","author":"Thomas","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib5","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","article-title":"Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"24","author":"Packer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib6","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1200\/JCO.2012.43.9984","article-title":"High-risk medulloblastoma: A pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031)","volume":"31","author":"Tarbell","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib7","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1200\/JCO.2010.34.4341","article-title":"Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934","volume":"30","author":"Ashley","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ijrobp.2016.09.046","article-title":"Results of COG ACNS0331: A phase III trial of involved-field radiotherapy (IFRT) and low dose craniospinal irradiation (LD-CSI) with chemotherapy in average-risk medulloblastoma: A report from the Children's Oncology Group","volume":"96","author":"Michalski","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib9","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1200\/JCO.2011.40.2792","article-title":"Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: A Children's Oncology Group Phase I\/II study","volume":"30","author":"Jakacki","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1470-2045(08)70342-5","article-title":"Conformal radiotherapy after surgery for paediatric ependymoma: A prospective study","volume":"10","author":"Merchant","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/pbc.24274","article-title":"Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: A report from the Children's Oncology Group","volume":"59","author":"Garvin","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: A report from the Children's Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib13","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/neuonc\/now038","article-title":"Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: A report of the Children's Oncology Group ACNS0423 study","volume":"18","author":"Jakacki","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/pbc.21154","article-title":"Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: A Children's Oncology Group phase II study","volume":"50","author":"Korones","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.2003.06.129","article-title":"Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma\u2014A report from the Intergroup Rhabdomyosarcoma Study IV","volume":"21","author":"Breneman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib16","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0360-3016(01)01709-6","article-title":"Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma\u2014A report from the IRSG","volume":"51","author":"Donaldson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ijrobp.2004.02.064","article-title":"Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV","volume":"59","author":"Michalski","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mpo.1259","article-title":"Treatment of children and adolescents with localized parameningeal sarcoma: Experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997","volume":"38","author":"Raney","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib19","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1200\/JCO.2001.19.20.4058","article-title":"Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the Children's Oncology Group","volume":"19","author":"Smith","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0360-3016(97)00120-X","article-title":"Radiation therapy for rhabdomyosarcoma: Local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II","volume":"38","author":"Wharam","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib21","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1200\/JCO.2004.08.124","article-title":"Failure pattern and factors predictive of local failure in rhabdomyosarcoma: A report of group III patients on the third Intergroup Rhabdomyosarcoma Study","volume":"22","author":"Wharam","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib22","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1200\/JCO.1999.17.11.3468","article-title":"Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III","volume":"17","author":"Wolden","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2011.06.2011","article-title":"Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: A report from the Children's Oncology Group D9602 study","volume":"83","author":"Breneman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pbc.22928","article-title":"Local control and outcome in children with localized vaginal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma committee of the Children's Oncology Group","volume":"57","author":"Walterhouse","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib25","doi-asserted-by":"crossref","first-page":"e26540","DOI":"10.1002\/pbc.26540","article-title":"45 Gy is not sufficient radiotherapy dose for group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group","volume":"64","author":"Ermoian","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib26","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2014.55.6787","volume":"32","author":"Walterhouse","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ijrobp.2015.08.040","article-title":"Local control for intermediate-risk rhabdomyosarcoma: Results from D9803 according to histology, group, site, and size: A report from the Children's Oncology Group","volume":"93","author":"Wolden","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijrobp.2010.01.053","article-title":"Local therapy for rhabdomyosarcoma of the hands and feet: Is amputation necessary? A report from the Children's Oncology Group","volume":"80","author":"La","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib29","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1200\/JCO.2010.29.0247","article-title":"Early treatment failure in intermediate-risk rhabdomyosarcoma: Results from IRS-IV and D9803\u2014A report from the Children's Oncology Group","volume":"28","author":"Minn","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ijrobp.2013.07.003","article-title":"The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: An analysis of IRS-IV and D9803","volume":"87","author":"Spalding","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib31","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1200\/JCO.2006.10.4257","volume":"25","author":"Burke","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib32","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1200\/JCO.2008.19.5933","article-title":"Prognostic significance of tumor response at the end of therapy in group III rhabdomyosarcoma: A report from the Children's Oncology Group","volume":"27","author":"Rodeberg","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib33","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ijrobp.2014.08.005","article-title":"Predicting outcome in patients with rhabdomyosarcoma: Role of [(18)f]fluorodeoxyglucose positron emission tomography","volume":"90","author":"Casey","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib34","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ijrobp.2010.03.050","article-title":"Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: A report from the Children's Oncology Group","volume":"80","author":"La","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ijc.29351","article-title":"Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee","volume":"137","author":"Rodeberg","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2010.01.058","article-title":"Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: A report from the Children's Oncology Group","volume":"80","author":"Million","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib37","doi-asserted-by":"crossref","first-page":"10008","DOI":"10.1200\/jco.2014.32.15_suppl.10008","article-title":"Risk-based treatment for nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children's Oncology Group study ARST0332","volume":"32","author":"Spunt","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib38","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ijrobp.2011.01.036","article-title":"Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803\u2014A report from the Children's Oncology Group","volume":"82","author":"Lin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib39","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0031","volume":"32","author":"Friedman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib40","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ijrobp.2016.07.015","article-title":"Predictive factor analysis of response-adapted radiation therapy for chemotherapy-sensitive pediatric Hodgkin lymphoma: Analysis of the Children's Oncology Group AHOD 0031 trial","volume":"96","author":"Charpentier","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib41","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2016.01.053","article-title":"A comparative evaluation of normal tissue doses for patients receiving radiation therapy for Hodgkin lymphoma on the Childhood Cancer Survivor Study and recent Children's Oncology Group trials","volume":"95","author":"Zhou","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib42","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1200\/JCO.2008.20.7738","article-title":"Radiation dose and breast cancer risk in the childhood cancer survivor study","volume":"27","author":"Inskip","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2014.10.042","article-title":"Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): A report from the Children's Oncology Group","volume":"92","author":"Dharmarajan","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib44","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJMoa020890","article-title":"Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone","volume":"348","author":"Grier","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib45","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1200\/JCO.2011.41.5703","article-title":"Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group","volume":"30","author":"Womer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cncr.29065","article-title":"Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group","volume":"121","author":"DuBois","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib47","unstructured":"Ahmed S. Local control in localized Ewing sarcoma: A report from the Children's Oncology Group. Presented at: Connective Tissue Oncology Society Annual Meeting; Nov 9-12, 2016; Lisbon, Portugal."},{"key":"10.1016\/j.ijrobp.2018.03.002_bib48","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1200\/JCO.2016.34.15_suppl.11000","article-title":"Efficacy of busulfan-melphalan high dose chemotherapy consolidation (BuMel) in localized high-risk Ewing sarcoma (ES): Results of EURO-EWING 99-R2 randomized trial (EE99R2Loc)","volume":"34","author":"Whelan","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib49","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1200\/JCO.2016.34.15_suppl.11001","volume":"34","author":"Dirksen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/cncr.24740","article-title":"The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)","volume":"116","author":"Haeusler","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/pbc.23063","article-title":"Local control of metastatic sites with radiation therapy in metastatic Ewing sarcoma and rhabdomyosarcoma","volume":"57","author":"Liu","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib52","doi-asserted-by":"crossref","first-page":"418270","DOI":"10.1155\/2014\/418270","article-title":"Stereotactic body radiotherapy for metastatic and recurrent Ewing sarcoma and osteosarcoma","volume":"2014","author":"Brown","year":"2014","journal-title":"Sarcoma"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1470-2045(03)01322-6","article-title":"Management of Wilms' tumour: Current practice and future goals","volume":"5","author":"Kalapurakal","year":"2004","journal-title":"Lancet Oncol"},{"issue":"Suppl","key":"10.1016\/j.ijrobp.2018.03.002_bib54","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1200\/jco.2015.33.15_suppl.10023","article-title":"Clinical outcome and biological predictors of relapse following nephrectomy only for very low risk Wilms tumor (VLR WT): A report from Children's Oncology Group AREN0532","volume":"33","author":"Fernandez","year":"2015","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"10.1016\/j.ijrobp.2018.03.002_bib55","doi-asserted-by":"crossref","first-page":"10010","DOI":"10.1200\/jco.2015.33.15_suppl.10010","article-title":"Outcome and prognostic factors in stage III favorable histology Wilms tumor (FHWT): A report from the Children's Oncology Group (COG) study AREN0532","volume":"33","author":"Fernandez","year":"2015","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"10.1016\/j.ijrobp.2018.03.002_bib56","doi-asserted-by":"crossref","first-page":"10011","DOI":"10.1200\/jco.2015.33.15_suppl.10011","article-title":"Omission of lung radiation in patients with stage IV favorable histology Wilms tumor (FHWT) showing complete lung nodule response after chemotherapy: A report from Children's Oncology Group study AREN0533","volume":"33","author":"Dix","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib57","doi-asserted-by":"crossref","first-page":"10001","DOI":"10.1200\/jco.2014.32.15_suppl.10001","article-title":"Treatment of stage IV favorable histology Wilms tumor with incomplete lung metastasis response after chemotherapy: A report from Children's Oncology Group study AREN0533","volume":"32","author":"David","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib58","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/SLA.0000000000002356","article-title":"Results of the first prospective multi-institutional treatment study in children with bilateral Wilms tumor (AREN0534): A report from the Children's Oncology Group","volume":"266","author":"Ehrlich","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib59","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1200\/JCO.2015.66.1140","article-title":"Association of chromosome 1q gain with inferior survival in favorable-histology Wilms tumor: A report from the Children's Oncology Group","volume":"34","author":"Gratias","year":"2016","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"10.1016\/j.ijrobp.2018.03.002_bib60","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijrobp.2016.06.289","article-title":"Final report of a prospective clinical trial of cardiac sparing whole-lung intensity modulated radiation therapy in patients with metastatic pediatric tumors","volume":"96","author":"Kalapurakal","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib61","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ijrobp.2012.05.024","article-title":"Advantages of whole-liver intensity modulated radiation therapy in children with Wilms tumor and liver metastasis","volume":"85","author":"Kalapurakal","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib62","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ijrobp.2012.05.036","article-title":"Cardiac-sparing whole lung IMRT in children with lung metastasis","volume":"85","author":"Kalapurakal","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib63","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrurol.2017.163","article-title":"Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol","volume":"14","author":"van den Heuvel-Eibrink","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0360-3016(02)04506-6","article-title":"Impact of radiotherapy for high-risk neuroblastoma: A Children's Cancer Group study","volume":"56","author":"Haas-Kogan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl","key":"10.1016\/j.ijrobp.2018.03.002_bib65","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.ijrobp.2014.05.539","article-title":"Extent of lymph node radiation coverage in high-risk neuroblastoma does not affect clinical outcome: A report from the COG A3973 study","volume":"90","author":"Haas-Kogan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib66","doi-asserted-by":"crossref","first-page":"LBA3","DOI":"10.1200\/JCO.2016.34.18_suppl.LBA3","article-title":"A phase 3 randomized clinical trial of tandem myeloablative autologous stem cell transplant using peripheral blood stem cells a consolidation therapy for high-risk neuroblastoma: A Children's Oncology Group study","volume":"34","author":"Park","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib67","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0959-8049(94)00509-4","article-title":"A new 123I-MIBG whole body scan scoring method\u2014Application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma","volume":"31A","author":"Ady","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib68","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2006-01-024729","article-title":"Risk and response-based classification of childhood B-precursor acute lymphoblastic leukemia: A combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)","volume":"109","author":"Schultz","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib69","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia","volume":"14","author":"Smith","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/pbc.24228","article-title":"Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia","volume":"60","author":"Richards","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib71","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.2015.64.2850","article-title":"Influence of cranial radiotherapy on outcome in children with acute lymphoblastic leukemia treated with contemporary therapy","volume":"34","author":"Vora","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib72","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/leu.2008.251","article-title":"Factors influencing survival after relapse from acute lymphoblastic leukemia: A Children's Oncology Group study","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib73","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1182\/blood-2005-12-4942","volume":"107","author":"Eapen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib74","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.bmt.1705515","article-title":"Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens","volume":"38","author":"Gassas","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib75","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1001\/jama.297.11.1207","article-title":"Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia","volume":"297","author":"Hijiya","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib76","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/leu.2009.257","article-title":"Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000","volume":"24","author":"Moricke","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib77","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1200\/JCO.2017.35.15_suppl.10506","article-title":"Intensive multi-modality therapy for extra-ocular retinoblastoma (RB): A Children's Oncology Group (COG) trial (ARET0321)","volume":"35","author":"Dunkel","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib78","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1200\/JCO.2016.34.15_suppl.10513","article-title":"Treatment of childhood nasopharyngeal carcinoma (cNPC) with neoadjuvant chemotherapy (NAC) and concomitant chemoradiotherapy (CCRT): Results of the Children's Oncology Group ARAR0331 study","volume":"34","author":"Rodriguez-Galindo","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib79","doi-asserted-by":"crossref","first-page":"e26338","DOI":"10.1002\/pbc.26338","article-title":"Late outcomes of adult survivors of childhood non-Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study","volume":"64","author":"Ehrhardt","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib80","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-152-7-201004060-00005","article-title":"A model-based estimate of cumulative excess mortality in survivors of childhood cancer","volume":"152","author":"Yeh","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib81","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1200\/JCO.2014.59.8052","article-title":"Collaborative research in childhood cancer survivorship: The current landscape","volume":"33","author":"Bhatia","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib82","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2014.11.034","article-title":"Radiotherapy quality assurance report from Children's Oncology Group AHOD0031","volume":"91","author":"Dharmarajan","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib83","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijrobp.2006.10.004","article-title":"Portal imaging practice patterns of Children's Oncology Group institutions: Dosimetric assessment and recommendations for minimizing unnecessary exposure","volume":"67","author":"Olch","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.addr.2016.11.006","article-title":"Proton therapy\u2014Present and future","volume":"109","author":"Mohan","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib85","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ijrobp.2007.08.027","article-title":"Radiation dose to the lens during craniospinal irradiation\u2014An improvement in proton radiotherapy technique","volume":"70","author":"Cochran","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib86","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ijrobp.2010.07.1989","article-title":"Proton radiotherapy for pediatric bladder\/prostate rhabdomyosarcoma: Clinical outcomes and dosimetry compared to intensity-modulated radiation therapy","volume":"81","author":"Cotter","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib87","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/neuonc\/nov302","article-title":"Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma","volume":"18","author":"Eaton","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib88","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fonc.2015.00261","article-title":"Secondary malignancy risk following proton radiation therapy","volume":"5","author":"Eaton","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib89","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/jayao.2013.0038","article-title":"Preserving fertility in adolescent girls and young women requiring craniospinal irradiation: A case report and discussion of options to be considered prior to treatment","volume":"3","author":"Lester-Coll","year":"2014","journal-title":"J Adolesc Young Adult Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib90","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13014-014-0220-8","article-title":"Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation","volume":"9","author":"Min","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib91","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijrobp.2015.06.012","article-title":"Early cognitive outcomes following proton radiation in pediatric patients with brain and central nervous system tumors","volume":"93","author":"Pulsifer","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib92","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3109\/0284186X.2014.887225","article-title":"Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors","volume":"53","author":"Song","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib93","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.radonc.2014.08.017","article-title":"Quality of life outcomes in proton and photon treated pediatric brain tumor survivors","volume":"113","author":"Yock","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib94","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1470-2045(15)00167-9","article-title":"Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: A phase 2 single-arm study","volume":"17","author":"Yock","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib95","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/cncr.29209","article-title":"Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children","volume":"121","author":"Mailhot Vega","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib96","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/leu.2016.192","article-title":"A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program","volume":"30","author":"Jones","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib97","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00280-016-3042-6","article-title":"Identifying novel therapeutic agents using xenograft models of pediatric cancer","volume":"78","author":"Kurmasheva","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2018.03.002_bib98","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1200\/JCO.2005.05.4171","article-title":"DNA repair pathways in clinical practice: Lessons from pediatric cancer susceptibility syndromes","volume":"24","author":"Kennedy","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618304942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618304942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:42:33Z","timestamp":1759743753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618304942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0360301618304942"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.03.002","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Children's Oncology Group Radiation Oncology Discipline: 15\u00a0Years of Contributions to the Treatment of Childhood Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}